Evaluation Thrombocytosis in CKD Stage V Patient on Hemodialysis Treatment : Case Report

Abstract

Chronic kidney disease (CKD), also known as renal failure, primarily affects people with a history of hypertension and diabetes. In this medical condition, the rate of filtration or kidney function can decrease over the course of a month or a year. Several studies have found an increase in pro-inflammatory cytokines in patients with CKD. Platelet dysfunction and hyperreactivity have been linked to chronic inflammation. When the platelet count exceeds 450,000/l, thrombocytosis occurs. It is also referred to as thrombocythemia. Reactive thrombocytosis accounts for 80-90% of all thrombocytosis events, with inflammation being one of the most common causes. We report a 67-year-old man presenting to the hospital with fever and weakness. The patient had a history of CKD stage V and currently was rceiving hemodialysis treatment. Laboratory finding showed patient had thrombocytosis. Further examination is required to determine the cause of thrombocytosis in CKD patient.